Cargando…

Discontinuation and nonpublication analysis of chronic pain randomized controlled trials

INTRODUCTION: The primary objective of this cross-sectional analysis is to evaluate rates of discontinuation and nonpublication of Randomized controlled trials (RCTs) of therapeutic interventions to treat chronic pain. METHODS: Using ClinicalTrials.gov, a sample was obtained which included clinical...

Descripción completa

Detalles Bibliográficos
Autores principales: Jacobsen, Samuel M., Moore, Ty, Douglas, Alexander, Lester, Drew, Johnson, Austin L., Vassar, Matt
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10079346/
https://www.ncbi.nlm.nih.gov/pubmed/37032814
http://dx.doi.org/10.1097/PR9.0000000000001069
_version_ 1785020709054971904
author Jacobsen, Samuel M.
Moore, Ty
Douglas, Alexander
Lester, Drew
Johnson, Austin L.
Vassar, Matt
author_facet Jacobsen, Samuel M.
Moore, Ty
Douglas, Alexander
Lester, Drew
Johnson, Austin L.
Vassar, Matt
author_sort Jacobsen, Samuel M.
collection PubMed
description INTRODUCTION: The primary objective of this cross-sectional analysis is to evaluate rates of discontinuation and nonpublication of Randomized controlled trials (RCTs) of therapeutic interventions to treat chronic pain. METHODS: Using ClinicalTrials.gov, a sample was obtained which included clinical trials pertaining to chronic pain. Trials were analyzed for publication status and completion status of each trial. If information was unavailable on the trial registry database, or could not be allocated through a systematic search, the corresponding trialist was contacted and data points were gathered. RESULTS: In our final analysis of the 408 RCTs, we found that 281 (68.9%) were published in a peer-reviewed journal and 127 (31.1%) were unpublished trials. Of 112 discontinued trials, 59 (52.7%) reached publication. In addition, 221 of 296 completed trials (74.7%) were published, and 75 (25.3%) remained unpublished after trial completion. The most common listed reason for trial discontinuation was administrative recommendations (41 of 71 trials [57.7%]), while not receiving an email reply to our standardized email from the corresponding trialist was the most common result for trial nonpublication (49 of 88 trials [55.7%]). Clinical trials funded by nonindustry sponsors were more likely to reach publication than industry-funded clinical trials (unadjusted odds ratio 1.86 [95% CI, 1.18–2.95]; adjusted odds ratio 3.01 [95% CI, 1.76–5.14]). CONCLUSION: The rate of discontinuation of RCTs involving patients with chronic pain is concerning. Chronic pain affects many patients; thus, the importance of having quality data from clinical trials cannot be overstated. Our study indicates that chronic pain RCTs are frequently discontinued and their findings often go unpublished — all of which could provide crucial information to providers and patients regarding the treatment of chronic pain. We offer suggestions to enhance chronic pain RCT completion, thereby reducing the waste of resources in chronic pain research.
format Online
Article
Text
id pubmed-10079346
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Wolters Kluwer
record_format MEDLINE/PubMed
spelling pubmed-100793462023-04-07 Discontinuation and nonpublication analysis of chronic pain randomized controlled trials Jacobsen, Samuel M. Moore, Ty Douglas, Alexander Lester, Drew Johnson, Austin L. Vassar, Matt Pain Rep General Section INTRODUCTION: The primary objective of this cross-sectional analysis is to evaluate rates of discontinuation and nonpublication of Randomized controlled trials (RCTs) of therapeutic interventions to treat chronic pain. METHODS: Using ClinicalTrials.gov, a sample was obtained which included clinical trials pertaining to chronic pain. Trials were analyzed for publication status and completion status of each trial. If information was unavailable on the trial registry database, or could not be allocated through a systematic search, the corresponding trialist was contacted and data points were gathered. RESULTS: In our final analysis of the 408 RCTs, we found that 281 (68.9%) were published in a peer-reviewed journal and 127 (31.1%) were unpublished trials. Of 112 discontinued trials, 59 (52.7%) reached publication. In addition, 221 of 296 completed trials (74.7%) were published, and 75 (25.3%) remained unpublished after trial completion. The most common listed reason for trial discontinuation was administrative recommendations (41 of 71 trials [57.7%]), while not receiving an email reply to our standardized email from the corresponding trialist was the most common result for trial nonpublication (49 of 88 trials [55.7%]). Clinical trials funded by nonindustry sponsors were more likely to reach publication than industry-funded clinical trials (unadjusted odds ratio 1.86 [95% CI, 1.18–2.95]; adjusted odds ratio 3.01 [95% CI, 1.76–5.14]). CONCLUSION: The rate of discontinuation of RCTs involving patients with chronic pain is concerning. Chronic pain affects many patients; thus, the importance of having quality data from clinical trials cannot be overstated. Our study indicates that chronic pain RCTs are frequently discontinued and their findings often go unpublished — all of which could provide crucial information to providers and patients regarding the treatment of chronic pain. We offer suggestions to enhance chronic pain RCT completion, thereby reducing the waste of resources in chronic pain research. Wolters Kluwer 2023-04-04 /pmc/articles/PMC10079346/ /pubmed/37032814 http://dx.doi.org/10.1097/PR9.0000000000001069 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of The International Association for the Study of Pain. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY) (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle General Section
Jacobsen, Samuel M.
Moore, Ty
Douglas, Alexander
Lester, Drew
Johnson, Austin L.
Vassar, Matt
Discontinuation and nonpublication analysis of chronic pain randomized controlled trials
title Discontinuation and nonpublication analysis of chronic pain randomized controlled trials
title_full Discontinuation and nonpublication analysis of chronic pain randomized controlled trials
title_fullStr Discontinuation and nonpublication analysis of chronic pain randomized controlled trials
title_full_unstemmed Discontinuation and nonpublication analysis of chronic pain randomized controlled trials
title_short Discontinuation and nonpublication analysis of chronic pain randomized controlled trials
title_sort discontinuation and nonpublication analysis of chronic pain randomized controlled trials
topic General Section
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10079346/
https://www.ncbi.nlm.nih.gov/pubmed/37032814
http://dx.doi.org/10.1097/PR9.0000000000001069
work_keys_str_mv AT jacobsensamuelm discontinuationandnonpublicationanalysisofchronicpainrandomizedcontrolledtrials
AT moorety discontinuationandnonpublicationanalysisofchronicpainrandomizedcontrolledtrials
AT douglasalexander discontinuationandnonpublicationanalysisofchronicpainrandomizedcontrolledtrials
AT lesterdrew discontinuationandnonpublicationanalysisofchronicpainrandomizedcontrolledtrials
AT johnsonaustinl discontinuationandnonpublicationanalysisofchronicpainrandomizedcontrolledtrials
AT vassarmatt discontinuationandnonpublicationanalysisofchronicpainrandomizedcontrolledtrials